Do you need a Crestor lawyer in Washington, DC? Contact one of our Crestor lawyers in Washington, DC now.
Home : Unsafe Drugs : Crestor : MSN Newsfeeds
Crestor - MSN Newsfeeds
- New Zealand Herald - Heart specialists are using the audit - commissioned by pharmaceutical company AstraZeneca - to press the Government to widen access to existing types of the cholesterol-lowering drugs and to pay for a new one made by Astra, rosuvastatin. It is the ...
- Medical News Today - Combining the most potent HMG-CoA reductase inhibitor rosuvastatin and cholesterol absorption inhibitor (CAI) ezetimibe leads to > 70 % reduction of LDL cholesterol. Both drugs showed a growth of 2006 sales of 59 % or 48 %, while the US$ 20.4 bln ...
- Baltimore Sun - Seroquel for schizophrenia; and Crestor for cutting blood cholesterol. Together, they accounted for 40 percent of the company's $26 billion in sales last year. So when MedImmune came on the market, AstraZeneca was willing to pay for promising products ...
- Portsmouth Herald - Today, we have Botox to thank for beautiful plastic faces of aging celebrities and Viagra, Levitra and Cialis for endless love. We have Lipitor, Zocor, Pravachol, Zetia, Vytorin and Crestor to facilitate consumption of 16-ounce steaks, buttery baked ...
- Gazette - AstraZeneca — makers of the cholesterol drug Crestor and the stomach acid treatment Nexium — reported first-quarter sales of $6.97 billion, an increase of 13 percent over the same quarter in 2006. Revenues in 2006 were $26.48 billion. The purchase ...
- Baltimore Sun - AstraZeneca PLC, formed from two companies in 1999, has grown into one of the world's largest pharmaceutical companies with 66,000 employees and $26.5 billion in sales last year. Based in London, it has a stable of top-selling drugs, including Crestor ...
- Canton Repository - AstraZeneca has struggled to regain investor confidence in the past couple of years after a challenge to its cholesterol-reducer Crestor, a clinical trial showing that its lung cancer drug Iressa did not help patients live longer, the rejection by U ...
- Boston Globe - AstraZeneca markets some of the world's top-selling treatments, including Crestor for high cholesterol and Nexium for heartburn, but has struggled to find drugs that could become future blockbusters. It abandoned development of one potential heart ...
- Philadelphia Daily News - The drugmaker's top products include the ulcer treatment Nexium, schizophrenia drug Seroquel, and cholesterol medicine Crestor. On Feb. 1, AstraZeneca said it would cut about 3,000 jobs, or about 4.6 percent of its workforce, in the next three years ...
- Washington Times - AstraZeneca has struggled to regain investor confidence over the past couple of years after a challenge to its cholesterol-reducer Crestor, a clinical trial showing that its lung cancer drug Iressa did not help patients live longer and the rejection ...
- Earthtimes - This has left the company with only three of its existing products -- Seroquel for schizophrenia, Crestor for cholesterol and Nexium for ulcer treatment -- to generate profit. The company is expected to merge MedImmune with Cambridge Antibody ...
- InteliHealth - A: One of the more common side effects of all the statin drugs (atorvastatin, fluvastatin, lovastatin, rosuvastatin, pravastatin, simvastatin) is muscle pain with or without muscle injury. The problem can occur at any time a person is taking a statin ...
- Street.Com - Worldwide sales of the cholesterol drug Crestor jumped 59% to $628 million, while U.S. sales grew 56% to $343 million. Like other brand-name cholesterol fighters, Crestor must cope with managed care companies and insurers that are encouraging ...
- Street.Com - AstraZeneca is one of the world's largest pharmaceuticals companies, and it's known for drugs like Zomig, Nexium and Crestor. Taking over MedImmune, it said, will give it the ability to significantly expand its efforts to develop biotechnology drugs ...
- Market Wire - The report, "Statins Cholesterol Treatment Competitive Landscape," found Lipitor to be the perceived market leader in discussion, with Crestor being the most positively discussed brand. The report also found that the majority of discussions ...
- Forbes - AstraZeneca in particular is widely reported to have one of the weakest new-product pipelines among big pharmaceutical companies, and it needs to act quickly to fill the hole left by patent expirations on big sellers like cholesterol-lowering Crestor ...
- Phramalive.com - Combined sales of five key growth products (Nexium™, Seroquel™, Crestor™, Arimidex™ and Symbicort™) increased by 17 percent to $3,614 million. • Free cash flow of $1,907 million in the first quarter. Cash distributions to shareholders ...
- MSN MoneyCentral - AZN, which relies on its top three selling drugs, Nexium, Seroquel, and Crestor, also announced first quarter earnings rose 9% to $1.56 billion on revenues of $6.97 billion. -- Kimberly DuBord, Briefing.com Briefing.com is the leading Internet ...
- Smart Money - The company's top drugs performed well during the quarter, with heart-burn drug Nexium up 10% to $1.31 billion, schizophrenia treatment Seroquel up 14% to $923 million and sales of cholesterol drug Crestor rising 62% to $628 million. AstraZeneca ...
- Forbes - Widely seen as having one of the weakest new product pipelines among large pharma companies, many observers have warned that AstraZeneca needs to act fast to plug the gap that will be created by patent expiries to top-sellers like Crestor and ...
Do you need a Crestor lawyer in Washington, DC? Contact one of our Crestor lawyers in Washington, DC now.
Pages: Previous 1 2 3 4 5 6 7 8 9 10 ... Next
